Department of Sense Organs, 9311Sapienza University of Rome, Rome, Italy.
Department of Otolaryngology and Head & Neck Surgery, IRCCS "18658Regina Elena" National Cancer Institute, Rome, Italy.
Ear Nose Throat J. 2021 Feb;100(1_suppl):51S-58S. doi: 10.1177/0145561320928198. Epub 2020 Jun 8.
The aim of the current systematic review is to update the pooled survival outcome of patients with T2 glottic carcinoma treated with either laser surgery (CO transoral laser microsurgery [CO TOLMS]), radiotherapy (RT), or open partial laryngectomy (OPL).
A systematic search was performed using the MEDLINE database, Scopus, and Google scholar. The inclusion criteria were studies of patients with T2N0 glottic tumor, treated with either primary CO TOLMS, definitive curative RT, or primary OPL, and with reported oncological outcome at 5 years calculated with a Kaplan-Meier or Cox regression method.
The results of the current review show that local control (LC) is higher with OPL 94.4%, while there are no differences in LC at 5-year posttreatment for patients treated with RT, compared to those treated with CO TOLMS (respectively, 75.6% and 75.4%). Primary treatment with OPL and CO TOLMS results in higher laryngeal preservation than primary treatment with RT (respectively 95.8%, 86.9%, and 82.4%).
First-line treatment with OPL and CO TOLMS should be encouraged in selected T2 patients, because it results in higher laryngeal preservation and similar LC compared to primary treatment with RT. The involvement of the anterior commissure in the craniocaudal plane and T2b impaired vocal cord mobility have a poorer prognosis and LC compared to patients with T2a tumors for both CO TOLMS and RT.
本系统评价的目的是更新 T2 声门型喉癌患者接受激光手术(CO 经口激光显微手术 [CO TOLMS])、放疗(RT)或开放性部分喉切除术(OPL)治疗的汇总生存结果。
使用 MEDLINE 数据库、Scopus 和 Google Scholar 进行系统检索。纳入标准为 T2N0 声带肿瘤患者的研究,接受原发性 CO TOLMS、根治性 RT 或原发性 OPL 治疗,并报告了采用 Kaplan-Meier 或 Cox 回归法计算的 5 年肿瘤学结果。
目前综述的结果表明,OPL 的局部控制率(LC)更高,为 94.4%,而接受 RT 治疗的患者与接受 CO TOLMS 治疗的患者在 5 年治疗后 LC 无差异(分别为 75.6%和 75.4%)。与 RT 相比,OPL 和 CO TOLMS 的原发性治疗导致更高的喉保留率(分别为 95.8%、86.9%和 82.4%)。
应鼓励在选定的 T2 患者中采用 OPL 和 CO TOLMS 作为一线治疗方法,因为与 RT 相比,其能提高喉保留率和相似的 LC。在前联合平面颅尾向累及和 T2b 型声带活动受限的患者中,CO TOLMS 和 RT 的 LC 较 T2a 肿瘤患者更差。